These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clinical practice. Bipolar disorder--a focus on depression. Frye MA. N Engl J Med; 2011 Jan 06; 364(1):51-9. PubMed ID: 21208108 [No Abstract] [Full Text] [Related]
3. Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials. Solmi M, Veronese N, Zaninotto L, van der Loos ML, Gao K, Schaffer A, Reis C, Normann C, Anghelescu IG, Correll CU. CNS Spectr; 2016 Oct 06; 21(5):403-418. PubMed ID: 27686028 [Abstract] [Full Text] [Related]
4. A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder. Soares-Weiser K, Bravo Vergel Y, Beynon S, Dunn G, Barbieri M, Duffy S, Geddes J, Gilbody S, Palmer S, Woolacott N. Health Technol Assess; 2007 Oct 06; 11(39):iii-iv, ix-206. PubMed ID: 17903393 [Abstract] [Full Text] [Related]
5. Treatment of bipolar depression: making sensible decisions. Citrome L. CNS Spectr; 2014 Dec 06; 19 Suppl 1():4-11; quiz 1-3, 12. PubMed ID: 25407667 [Abstract] [Full Text] [Related]
7. Olanzapine is superior to lamotrigine in the prevention of bipolar depression: a naturalistic observational study. Pan PY, Lee MS, Lo MC, Yang EL, Yeh CB. BMC Psychiatry; 2014 May 19; 14():145. PubMed ID: 24885966 [Abstract] [Full Text] [Related]
9. Treatments for late-life bipolar disorder. Aziz R, Lorberg B, Tampi RR. Am J Geriatr Pharmacother; 2006 Dec 19; 4(4):347-64. PubMed ID: 17296540 [Abstract] [Full Text] [Related]
10. A review of FDA-approved treatment options in bipolar depression. McIntyre RS, Cha DS, Kim RD, Mansur RB. CNS Spectr; 2013 Dec 19; 18 Suppl 1():4-20; quiz 21. PubMed ID: 24237641 [Abstract] [Full Text] [Related]
11. Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone. Nierenberg AA, Ostacher MJ, Calabrese JR, Ketter TA, Marangell LB, Miklowitz DJ, Miyahara S, Bauer MS, Thase ME, Wisniewski SR, Sachs GS. Am J Psychiatry; 2006 Feb 19; 163(2):210-6. PubMed ID: 16449473 [Abstract] [Full Text] [Related]
12. Newer treatment studies for bipolar depression. Gao K, Calabrese JR. Bipolar Disord; 2005 Feb 19; 7 Suppl 5():13-23. PubMed ID: 16225556 [Abstract] [Full Text] [Related]
13. Bipolar disorder: an update. El-Mallakh RS, Elmaadawi AZ, Loganathan M, Lohano K, Gao Y. Postgrad Med; 2010 Jul 19; 122(4):24-31. PubMed ID: 20675968 [Abstract] [Full Text] [Related]
14. Treatment of bipolar depression: an update. Fountoulakis KN, Grunze H, Panagiotidis P, Kaprinis G. J Affect Disord; 2008 Jul 19; 109(1-2):21-34. PubMed ID: 18037498 [Abstract] [Full Text] [Related]
15. Treatment-resistant bipolar disorder. Gitlin M. Mol Psychiatry; 2006 Mar 19; 11(3):227-40. PubMed ID: 16432528 [Abstract] [Full Text] [Related]
16. Clinical highlights in bipolar depression: focus on atypical antipsychotics. Calabrese JR, Elhaj O, Gajwani P, Gao K. J Clin Psychiatry; 2005 Mar 19; 66 Suppl 5():26-33. PubMed ID: 16038599 [Abstract] [Full Text] [Related]
17. Clinical inquiries: what drugs are best for bipolar depression? Ukaegbu C, Banks JB, Carter NJ, Goldman LS. J Fam Pract; 2008 Sep 19; 57(9):606-8. PubMed ID: 18786334 [Abstract] [Full Text] [Related]
18. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007. Yatham LN, Kennedy SH, O'Donovan C, Parikh SV, MacQueen G, McIntyre RS, Sharma V, Beaulieu S, Guidelines Group, CANMAT. Bipolar Disord; 2006 Dec 19; 8(6):721-39. PubMed ID: 17156158 [Abstract] [Full Text] [Related]
19. A clinical review of aripiprazole in bipolar depression and maintenance therapy of bipolar disorder. Yatham LN. J Affect Disord; 2011 Jan 19; 128 Suppl 1():S21-8. PubMed ID: 21220077 [Abstract] [Full Text] [Related]
20. Antidepressant discontinuation in bipolar depression: a Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) randomized clinical trial of long-term effectiveness and safety. Ghaemi SN, Ostacher MM, El-Mallakh RS, Borrelli D, Baldassano CF, Kelley ME, Filkowski MM, Hennen J, Sachs GS, Goodwin FK, Baldessarini RJ. J Clin Psychiatry; 2010 Apr 19; 71(4):372-80. PubMed ID: 20409444 [Abstract] [Full Text] [Related] Page: [Next] [New Search]